Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations

on behalf of the PRIORITIZE HCV Study Group

doi:10.1177/1740774520941257

Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations

on behalf of the PRIORITIZE HCV Study Group

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	729-731
Number of pages	3
Journal	Clinical Trials
Volume	17
Issue number	6
DOIs	https://doi.org/10.1177/1740774520941257
State	Published - Dec 1 2020

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1177/1740774520941257

Cite this

@article{7bd67a8ce67144648561309fcaa72d48,

title = "Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations",

author = "{on behalf of the PRIORITIZE HCV Study Group} and Segal, {Jodi B.}",

note = "Funding Information: The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grant from the Patient-Centered Outcomes Research Institute. ",

year = "2020",

month = dec,

day = "1",

doi = "10.1177/1740774520941257",

language = "English (US)",

volume = "17",

pages = "729--731",

journal = "Clinical Trials",

issn = "1740-7745",

publisher = "SAGE Publications Ltd",

number = "6",

}

TY - JOUR

T1 - Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations

AU - on behalf of the PRIORITIZE HCV Study Group

AU - Segal, Jodi B.

N1 - Funding Information: The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grant from the Patient-Centered Outcomes Research Institute.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85087789091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087789091&partnerID=8YFLogxK

U2 - 10.1177/1740774520941257

DO - 10.1177/1740774520941257

M3 - Letter

C2 - 32650667

AN - SCOPUS:85087789091

SN - 1740-7745

VL - 17

SP - 729

EP - 731

JO - Clinical Trials

JF - Clinical Trials

IS - 6

ER -

Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this